<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02079311</url>
  </required_header>
  <id_info>
    <org_study_id>MD13-001</org_study_id>
    <nct_id>NCT02079311</nct_id>
  </id_info>
  <brief_title>Evaluation of Core Body Temperature When Using Forced Air Warming or an Active Blanket to Prevent Perioperative Hypothermia</brief_title>
  <official_title>Evaluation of Perioperative Core Body Temperature When Using Forced Air Warming or BARRIER® EasyWarm to Prevent Inadvertent Perioperative Hypothermia: An Open-label, Randomized Non-inferiority Comparison</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is undertaken to investigate if patient warming with BARRIER® EasyWarm
      active self-warming blanket differs compared to active warming with forced air warming in
      terms of core body temperature perioperatively.

      A non-inferiority, prospective, open-labelled, randomized, parallel investigation.

      Randomized subjects will receive active warming with BARRIER® EasyWarm or with forced air
      warming. All subjects may receive rescue warming if their core temperature falls below
      35.5°C. Rescue warming is optional and defined as the institution's standard of care to
      prevent hypothermia.

      The primary purpose is to investigate if there is a clinically relevant difference in core
      body temperature between the two treatment groups.

      A total of 60 subjects will be included in the investigation, i.e. 30 subjects in each
      treatment group. The number includes a 30% drop-out rate.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Difference in Core Body Temperature in the Two Treatment Groups.</measure>
    <time_frame>Subjects will be followed for one day of hospital stay, data to be collected during the perioperative phase. Expected to be between 5-8 hours.</time_frame>
    <description>Temperature assessments will be made using an oesophageal temperature probe when the subject is under general anaesthesia and by oral thermometer for all other temperature assessments performed in pre-, intra- and post-op. The mean value is calculated on all temperature measured during pre-, intra- and post-op.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Inadvertent Perioperative Hypothermia</condition>
  <condition>Preoperative Anxiety Experienced by the Patient</condition>
  <arm_group>
    <arm_group_label>Active self-warming blanket</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active warming with BARRIER® EasyWarm active self-warming blanket during the perioperative phase</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Forced air warming device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active warming with forced air warming (FAW) during the intraoperative phase.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active self warming blanket</intervention_name>
    <description>BARRIER® EasyWarm is a disposable self-warming blanket that produces heat via an exothermic chemical reaction initiated by exposure to air, resulting from the oxidation of iron.</description>
    <arm_group_label>Active self-warming blanket</arm_group_label>
    <other_name>BARRIER® EasyWarm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Forced air warming device</intervention_name>
    <description>Forced air warming is a temperature management unit, where heated air is used to warm subjects through convection.</description>
    <arm_group_label>Forced air warming device</arm_group_label>
    <other_name>Bair Hugger™</other_name>
    <other_name>Equator® level 1.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of informed consent i.e. subject must be able to understand and sign the
             Informed Consent Form (ICF)

          -  Male and female subjects aged 18 years and over

          -  Subject scheduled for surgery with a minimum length of 60 minutes and a maximum length
             of 120 minutes

          -  Scheduled surgery must be performed entirely under general anaesthesia

          -  The subject must be able to receive temperature assessments via an oesophageal
             temperature probe when under general anaesthesia and via an oral thermometer before
             and after general anaesthesia as well as in the pre- and post-op area

          -  The subject must have an oral temperature measurement of at least 36.0°C when first
             measured in the preoperative setting

          -  The subject's scheduled surgical procedure must allow time to be warmed with a fully
             activated BARRIER® EasyWarm at least 30 minutes prior to induction of general
             anaesthesia

        Exclusion Criteria:

          -  Subjects with an American Society of Anesthesiologists (ASA) rating of 4 or greater

          -  Known Diabetes with an HbA1c of more than 6 %

          -  Relevant medical history (e.g., neuropathy, peripheral vascular disease, circulatory
             disorder or other) that presents risk to/of:

               1. The subject's normal temperature regulation or

               2. Perception of external temperature or

               3. Subcutaneous lipoatrophy

          -  Current use of concomitant medications that present relevant risk to/of:

               1. The subject's normal temperature regulation or

               2. Perception of external temperature or

               3. Subcutaneous lipoatrophy

          -  Epidural/Spinal anaesthesia

          -  An oral temperature measurement ≥ 37.5°

          -  Contraindications to the oesophagus temperature probe and oral thermometer

          -  Presence of skin and soft tissue disorders in areas covered directly by the device in
             the two treatment groups (e.g. pressure ulcers, clinically significant psoriasis,
             dermatitis or any other interruption of skin integrity that would be affected by
             direct heat)

          -  Pregnancy

          -  Severe non-compliance to protocol as judged by the investigator and/or Mölnlycke
             Health Care
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Torossian, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Gießen und Marburg GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg GmbH</name>
      <address>
        <city>Marburg</city>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ullevål - Oslo Universitetssykehus</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hallamshire Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 2SB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Norway</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2014</study_first_submitted>
  <study_first_submitted_qc>March 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <results_first_submitted>September 1, 2015</results_first_submitted>
  <results_first_submitted_qc>October 14, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 13, 2015</results_first_posted>
  <last_update_submitted>October 14, 2015</last_update_submitted>
  <last_update_submitted_qc>October 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patient warming</keyword>
  <keyword>Active warming</keyword>
  <keyword>Forced Air Warming</keyword>
  <keyword>Warming blanket</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active Self-warming Blanket</title>
          <description>Active warming with BARRIER® EasyWarm active self-warming blanket during the perioperative phase
Active self warming blanket: BARRIER® EasyWarm is a disposable self-warming blanket that produces heat via an exothermic chemical reaction initiated by exposure to air, resulting from the oxidation of iron.</description>
        </group>
        <group group_id="P2">
          <title>Forced Air Warming Device</title>
          <description>Active warming with forced air warming (FAW) during the intraoperative phase.
Forced air warming device: Forced air warming is a temperature management unit, where heated air is used to warm subjects through convection.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active Self-warming Blanket</title>
          <description>Active warming with BARRIER® EasyWarm active self-warming blanket during the perioperative phase
Active self warming blanket: BARRIER® EasyWarm is a disposable self-warming blanket that produces heat via an exothermic chemical reaction initiated by exposure to air, resulting from the oxidation of iron.</description>
        </group>
        <group group_id="B2">
          <title>Forced Air Warming Device</title>
          <description>Active warming with forced air warming (FAW) during the intraoperative phase.
Forced air warming device: Forced air warming is a temperature management unit, where heated air is used to warm subjects through convection.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49" spread="13.2"/>
                    <measurement group_id="B2" value="50" spread="14.44"/>
                    <measurement group_id="B3" value="49.5" spread="13.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>2 subject were enrolled but not randomised.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Difference in Core Body Temperature in the Two Treatment Groups.</title>
        <description>Temperature assessments will be made using an oesophageal temperature probe when the subject is under general anaesthesia and by oral thermometer for all other temperature assessments performed in pre-, intra- and post-op. The mean value is calculated on all temperature measured during pre-, intra- and post-op.</description>
        <time_frame>Subjects will be followed for one day of hospital stay, data to be collected during the perioperative phase. Expected to be between 5-8 hours.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Self-warming Blanket</title>
            <description>Active warming with BARRIER® EasyWarm active self-warming blanket during the perioperative phase
Active self warming blanket: BARRIER® EasyWarm is a disposable self-warming blanket that produces heat via an exothermic chemical reaction initiated by exposure to air, resulting from the oxidation of iron.</description>
          </group>
          <group group_id="O2">
            <title>Forced Air Warming Device</title>
            <description>Active warming with forced air warming (FAW) during the intraoperative phase.
Forced air warming device: Forced air warming is a temperature management unit, where heated air is used to warm subjects through convection.</description>
          </group>
        </group_list>
        <measure>
          <title>The Difference in Core Body Temperature in the Two Treatment Groups.</title>
          <description>Temperature assessments will be made using an oesophageal temperature probe when the subject is under general anaesthesia and by oral thermometer for all other temperature assessments performed in pre-, intra- and post-op. The mean value is calculated on all temperature measured during pre-, intra- and post-op.</description>
          <units>degree celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.28" spread="0.3"/>
                    <measurement group_id="O2" value="36.25" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active Self-warming Blanket</title>
          <description>Active warming with BARRIER® EasyWarm active self-warming blanket during the perioperative phase
Active self warming blanket: BARRIER® EasyWarm is a disposable self-warming blanket that produces heat via an exothermic chemical reaction initiated by exposure to air, resulting from the oxidation of iron.</description>
        </group>
        <group group_id="E2">
          <title>Forced Air Warming Device</title>
          <description>Active warming with forced air warming (FAW) during the intraoperative phase.
Forced air warming device: Forced air warming is a temperature management unit, where heated air is used to warm subjects through convection.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_vocab>skin and subcutane</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>redness</sub_title>
                <description>redness of skin vanished quickly without treatment</description>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title vocab="hematoma">hematoma</sub_title>
                <description>Hematoma on the left gluteus maximus and the right knee. Not related to investigational product.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title vocab="anaphylactic shock">anaphylactic shock</sub_title>
                <description>Anaphylactic shock due to blue methylene intracutan injection. The subject was planned to have a breast surgery due to cancer mammae.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Investigator shall provide the Sponsor with a draft of the manuscript intended for publication or presentation at least [14] days before the date of intended submission for publication. However the Sponsor should be notified about the intention to publish the results at least [14] days before the manuscript is sent for review. All comments and suggested changes made by the Sponsor shall be considered in good faith in determining the final form of such publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof Alexander Torossian</name_or_title>
      <organization>Universitätsklinikum Gießen und Marburg GmbH</organization>
      <phone>(+49) 06421 - 286 9864</phone>
      <email>alexander.torossian@med.uni-marburg.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

